|
...rather than regular review time of 10 months, says Curt Rosebraugh, M.D., M.P.H., deputy director of the FDA's Office of Drug Evaluation II. "Chantix underwent priority review," Rosebraugh says, "because at the time the application was filed, a preliminary review of the efficacy studies indicated that smokers treated with Chantix may...
NOTE: All illustrations and photos
have been removed from this article.
More articles from FDA Consumer
First treatment for Pompe disease.(Myozyme from Genzyme Corp. )(Brief ..., July 01, 2006
Humanitarian Device treats rare twin syndrome.(Fetoscopy Instrument Se..., July 01, 2006
Observations.(elder persons)(Editorial), July 01, 2006
Take the FDA consumer quiz., July 01, 2006
Investigators' reports: executives convicted in device scheme.(Ross A...., July 01, 2006
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
%20%20&position=1)